Pharmaceutical Gel Spreadability Testing: Step-by-Step Texture Analyzer Protocol

Step-by-step pharmaceutical gel spreadability test protocol using the KHT TA-30 texture analyzer — Ortan cone method, force-curve calculations, USP <1724> alignment.

The pharmaceutical gel spreadability test is an instrumented method that measures the work required to force a pharmaceutical gel to flow between two matched conical surfaces, producing a quantitative "spreadability energy" value in N·mm that correlates directly with patient-perceived ease of application. Conducted on a texture analyzer such as the KHT TA-30 using the Ortan 45°/90° spreadability rig, this test provides the primary instrumental readout for topical drug product characterisation under USP <1724> Semi-Solid Drug Products — Performance Tests, and is widely used as both a formulation screening tool and a release specification for topical gels, hydrogels, mucoadhesive gels and soft ointments. A complete spreadability test takes under one minute per replicate, uses only 5–10 g of sample, and delivers a force-distance curve from which peak force, area-under-curve (spreadability energy) and firmness can all be extracted simultaneously.

What Is Spreadability and Why It Matters for Topical Drug Products

Spreadability is formally defined as the ease with which a semi-solid formulation distributes across a substrate under a defined shear geometry. In the pharmaceutical context it is the single most important texture attribute for patient acceptance of topical drug products: a gel or cream that is difficult to spread produces uneven drug distribution, patchy therapy, unpleasant application sensation, and ultimately poor patient compliance. Regulatory bodies have correspondingly strengthened their expectations — spreadability data now appears routinely in ANDA and MAA submissions for topical generics, in topical bioequivalence (Q3 microstructure) data packages, and in ICH Q1 stability programmes where change in spreadability signals base degradation long before visual inspection would detect it.

Historically, spreadability was measured by the "parallel plate" method of Mutimer et al. (1956): a weighed sample was placed between two glass plates, a defined weight was added for a defined time, and the resulting spread diameter was measured. Variants are still used (the slip-plane extensometer, the Ortan falling-cone method). These gravimetric techniques suffer from three serious limitations in a modern GMP environment: (1) they rely on operator-dependent visual readings with poor precision (%RSD often >20%); (2) they produce a single scalar result (a diameter) rather than a force-distance curve, losing information about yield behaviour and recovery; (3) they cannot be integrated into electronic records or 21 CFR Part 11 audit trails. Instrumented spreadability on a texture analyzer replaces all three shortcomings with a digital, audit-trailed, information-rich measurement.

The physical principle of the texture analyzer method is straightforward. Two matched cones — a female cone (cavity) containing the product and a male cone (probe) of the same included angle — are driven together at controlled speed. As the male cone descends, product is forced outward along the conical gap. The force rises steeply at first (yield onset), passes through a peak, and plateaus or declines as the gap narrows and flow stabilises. The area under the force-distance curve is the mechanical work performed on the product, with units of N·mm (equivalent to mJ). This spreadability energy is the pharmacopoeial-style parameter most often cited in topical drug specifications.

Spreadability is also strongly temperature-dependent. Gels typically soften 10–25% per 5 °C rise. For reproducible work, samples must be conditioned at 25.0 ± 0.5 °C; for skin-contact simulation, 32 °C Peltier-controlled fixtures are available. The KHT TA-30 supports both ambient and Peltier-controlled testing without fixture changes.

Spreadability Test Equipment: Spreadability Rig vs. Cone Geometry

The spreadability rig is a purpose-built fixture consisting of two components: a female cone mounted in a heavy base (the sample holder) and a male cone mounted on the load cell. Two standard included angles are in common pharmaceutical use:

  • 90° cone (flat-sided, shallow): the default geometry for most pharmaceutical gels, hydrogels and soft creams. The shallow angle produces a broad, low-peak force curve that is sensitive to small differences in product consistency. Force ranges 0.1–5 N are typical.
  • 45° cone (steep-sided, deep): used for firmer semi-solids such as medicated petrolatum ointments and zinc oxide pastes. The steep angle produces higher peak forces (2–20 N) and is less prone to side leakage with stiff products.

Both cone angles trace back to the original Ortan research programme in the 1970s, and both are referenced in USP <1724> as acceptable geometries for spreadability characterisation. The KHT TA-30 supplies a matched 45°/90° pair as standard; procurement of supplementary geometries (30°, 60°, 120°) is available for non-standard investigations.

A common point of confusion is the difference between the spreadability rig and the TPA flat probe. A flat-probe TPA test will also produce a force-distance curve and can yield a "firmness" value, but it does not simulate the spreading geometry and therefore does not correlate reliably with patient-perceived ease of application. The two tests are complementary, not interchangeable: TPA provides bulk consistency (hardness, cohesiveness, springiness, adhesiveness), while the spreadability rig provides the application-geometry parameter (spreadability energy). A complete pharmaceutical gel characterisation typically runs both. For the full TPA method, see the TPA guide for pharmaceuticals.

Fixture materials matter. For topical drug products that contain organic solvents (alcohols, propylene glycol, oily vehicles), stainless steel 316L cones are preferred over aluminium to avoid corrosion and API interaction. Cones should be polished to Ra < 0.4 µm to ensure reproducible surface shear conditions; scored or worn cones introduce systematic errors of 5–15% and must be replaced per preventive maintenance schedule. The KHT TA-30 fixture programme includes an annual wear inspection as part of the included calibration service.

A note on budget-vs.-enterprise fixture pricing. Enterprise brands typically price a single spreadability rig at $1,200–$2,800; the proprietary fastener on the load cell locks the lab into the vendor's fixture ecosystem at 10–20% annual recurring cost. The KHT TA-30 uses a universal threaded interface (M6 standard) and publishes the full spreadability rig price ($380 for the matched 45°/90° pair) on the probes and accessories page — no inquiry required.

KHT TA-30 Setup: Speed, Distance, Pre-Test & Trigger Conditions

Before the first test, four instrument parameters must be set: load cell, test speed, travel distance, and trigger force. The following values are the KHT TA-30 defaults for the pharmaceutical gel spreadability test and align with USP <1724> supportive guidance and published pharmacopoeial practice.

Load cell: 5 kg. At 0.01 N resolution, this cell comfortably covers the full 0.1–20 N force envelope of pharmaceutical gels, hydrogels and soft ointments. A 500 g cell is available for ultra-low-force hydrogel characterisation but is not required for routine work.

Test speed: 3.0 mm/s. This speed is a long-standing pharmacopoeial convention that balances reproducibility (a too-slow speed amplifies wall slip artefacts) against physiological relevance (a too-fast speed departs from the 1–10 mm/s range of finger-spreading). For consistency across laboratories, 3.0 mm/s should be retained unless method development explicitly demonstrates a different speed is needed.

Pre-test speed: 2.0 mm/s — the speed at which the probe approaches the sample surface before the trigger force is reached.

Post-test (withdrawal) speed: 10 mm/s — fast enough that withdrawal does not contribute noise to the result, slow enough to avoid fixture vibration.

Trigger force: 0.05 N. This is the force at which the instrument defines "probe contact" and zeroes the distance reading. A 0.05 N threshold is a good balance: sensitive enough to detect the top of a low-viscosity hydrogel, robust enough to reject acoustic noise and platform drift.

Travel distance (test depth): 23.0 mm. This is the standard full-descent depth for the 90° spreadability cone — the depth at which the male cone is fully seated in the female cone. For the 45° cone, standard depth is 15.0 mm. These values are preset in the KHT TA-30 method library.

Data acquisition rate: 500 Hz. At a test speed of 3.0 mm/s and a travel of 23 mm, this yields 3,800 data points per curve — sufficient resolution to resolve yield behaviour, peak force and integrated area with less than 0.1% digitisation error.

Dwell: none for standard spreadability. Optional 5-second dwell at peak depth for "bioadhesion-like" protocols.

Sample mass: 6–8 g for the 90° cone, 10–12 g for the 45° cone. Underfilling the female cone produces a truncated force curve (the probe descends into air before contacting product); overfilling causes side overflow and erratic peak force. The KHT method library specifies a recommended fill mark on the female cone for each geometry.

Temperature: 25.0 ± 0.5 °C for ambient testing. For skin-contact simulation, the Peltier platform can be programmed to 32.0 ± 0.2 °C. Condition samples at the target temperature for 4 hours minimum before testing.

Replicates: Minimum five per sample. Report mean ± SD and %RSD. Method validation per ICH Q2 typically targets %RSD ≤ 10% for peak force and ≤ 12% for spreadability energy.

Key Results: Spreadability Energy, Peak Force & Area Under Curve

A well-executed gel spreadability test on the KHT TA-30 produces a characteristic force-distance curve with three resolvable regions: an initial yield rise, a rounded peak, and a gradual plateau or decline as the male cone approaches full insertion. From this curve, the software automatically extracts the following parameters.

1. Peak force (Firmness). The maximum force recorded during the downstroke, in newtons. Peak force correlates with the yield stress of the gel — the force needed to initiate flow. Typical ranges by product class:

Product classPeak force (90° cone, 3.0 mm/s)
Low-viscosity aqueous hydrogel (ocular, nasal)0.1–0.6 N
Carbomer-based topical gel (1% gel strength)0.6–2.5 N
High-viscosity mucoadhesive gel (buccal, vaginal)1.5–5 N
Soft medicated ointment (petrolatum-light)2–8 N
Zinc oxide paste (40% ZnO)8–20 N

2. Spreadability energy (Work of Spread). The area under the force-distance curve, integrated from the trigger point to the end of the downstroke, in N·mm (equivalent to mJ). This is the most widely cited parameter in pharmacopoeial and regulatory contexts because it captures the full energetic cost of application rather than a single force point. Calculation:

Spreadability Energy (N·mm) = ∫ F(d) · dd, from d=0 to d=23 mm

In the KHT TA-30 software, this integration is performed automatically using the trapezoidal rule on the 500 Hz data. Typical ranges:

Product classSpreadability energy (90° cone, 23 mm depth)
Low-viscosity hydrogel1–8 N·mm
Standard carbomer gel5–25 N·mm
Mucoadhesive gel15–60 N·mm
Soft ointment30–150 N·mm

3. Work of Adhesion / Negative Area. If the test method includes a withdrawal phase with data acquisition enabled, the negative area under the curve during cone withdrawal quantifies the work of adhesion, in N·mm. This parameter is useful for mucoadhesive gels where tissue retention is a critical quality attribute. Typical range: 0.1–5 N·mm.

4. Gradient (Consistency Index). The slope of the force-distance curve over a defined distance window (commonly the first 5 mm of compression) provides a shorthand "consistency index" in N/mm. This is useful for rapid batch-to-batch comparison and can be specified as an acceptance criterion in the release specification.

A comment on precision. On a well-calibrated KHT TA-30 with 0.01 N load cell resolution and 0.001 mm distance resolution, intra-sample %RSD for peak force typically runs 3–6% and for spreadability energy 5–10%. Enterprise instruments achieve similar precision; budget instruments with coarser load cells (0.1 N resolution) and lower data acquisition rates (100 Hz) typically show 15–25% %RSD on the same samples — a level of variability that is incompatible with a pharmaceutical release specification.

Documentation, Specification Setting & GMP Batch Record Integration

The final step of the pharmaceutical gel spreadability test workflow is the transfer of results into the GMP batch record. Three elements matter.

Electronic record integrity (21 CFR Part 11). Every test run on the KHT TA-30 is automatically recorded in a Part 11-compliant audit trail: user login ID, date and time, instrument serial number, method ID, load cell and fixture IDs, all raw force-distance data at 500 Hz, all derived parameters, and any user-initiated modifications with justifications. The record is cryptographically signed and cannot be modified without generating a new audit entry. Records can be exported as PDF for batch documentation or as CSV for statistical analysis. This Part 11 functionality ships as standard with every KHT TA-30 — not as an "advanced software edition" upgrade.

Specification setting. A release specification for a pharmaceutical gel product typically includes the following texture elements:

  • Peak force: mean within range of X ± Y N (based on three validation batches ± 3σ)
  • Spreadability energy: mean within range of A ± B N·mm
  • Number of replicates: minimum 5, maximum 10
  • Acceptance criteria: n ≥ 5 individual measurements within range; mean %RSD ≤ 12%

The specification limits are set during method validation using three consecutive batches of reference product; the mean ± 3 standard deviations form the initial acceptance window, subject to tightening as process capability improves.

Method validation (ICH Q2). A validated spreadability method must demonstrate specificity (no interference from packaging residue or excipients), precision (repeatability %RSD and intermediate precision %RSD), accuracy (with a reference batch or a certified standard gel), linearity (across a product concentration range if relevant), range, detection limit (less relevant for bulk texture), quantitation limit, and robustness (variation with speed, temperature and sample mass). The KHT TA-30 GMP validation package includes pre-built protocols for each of these ICH Q2 elements, including the statistical analysis templates.

GMP batch record integration. The KHT TA-30 software supports direct export to the most common GMP batch record systems via signed PDF or XML. For laboratories operating a LIMS, an OPC-UA connector is available for automated transfer of certified results. SOP-locked methods prevent operators from modifying validated parameters without an e-signature approval workflow — a key requirement for multi-facility batch consistency.

A final cost note. Enterprise brand instruments typically charge $3,500–$6,500 for the 21 CFR Part 11 software module, plus $2,000–$4,000 for the GMP validation package, plus $800–$3,000 per year for mandatory calibration. Over a five-year ownership horizon, these recurring and optional line items add up to $15,000–$30,000 on top of the instrument price — costs which are either included or disclosed transparently in the KHT TA-30 pricing. See the price guide for the full five-year TCO breakdown.

Test Method Details

ItemSpecification
Primary fixture90° Ortan matched spreadability cone pair (male + female)
Alternative fixture45° cone pair for stiff ointments
MaterialStainless steel 316L, Ra < 0.4 µm
Load cell5 kg, 0.01 N resolution
Test speed3.0 mm/s
Pre-test speed2.0 mm/s
Post-test speed10 mm/s
Travel distance23 mm (90°) / 15 mm (45°)
Trigger force0.05 N
Data acquisition rate500 Hz
Sample mass6–8 g (90°) / 10–12 g (45°)
Temperature25.0 ± 0.5 °C standard; 32.0 ± 0.2 °C for skin simulation
Replicates5 minimum

Key TPA Parameters for Semi-Solids

Although the primary deliverable of spreadability testing is the spreadability energy (N·mm), a full pharmaceutical gel characterisation also considers the TPA-derived parameters measured with a flat cylindrical probe:

ParameterTypical Range (Pharma Gels)Method
Hardness (peak force, 1st bite)0.1–3 NTPA, 25 mm flat probe, 50% strain
Cohesiveness (A2/A1)0.3–0.7TPA, double compression
Springiness0.4–0.9TPA, distance ratio
Adhesiveness (negative area)0.05–1.5 N·sTPA withdrawal phase
Spreadability energy1–60 N·mm90° spreadability rig
Peak force (spreadability)0.1–5 N90° spreadability rig

Step-by-Step Protocol

The numbered procedure below is the KHT TA-30 pharmacopoeial-style protocol for the pharmaceutical gel spreadability test, suitable for inclusion as an SOP in a GMP laboratory.

  1. Sample preparation. Weigh 6.0 ± 0.1 g of conditioned product (25.0 ± 0.5 °C, 4-hour conditioning minimum) and transfer to the 90° female cone, filling to the marked line. Press gently with a spatula to eliminate entrained air. Avoid overfilling.
  2. Instrument preparation. Power on the KHT TA-30 and log in under the operator account. Install the 5 kg load cell. Install the 90° male cone on the load cell using the M6 threaded interface and torque to 2.0 N·m.
  3. Method recall. From the method library, select "Gel Spreadability 90° — USP <1724> Aligned". Verify method parameters (speed 3.0 mm/s, travel 23 mm, trigger 0.05 N, acquisition 500 Hz). The method ID, version and electronic approval record display in the header.
  4. Tare. With the male cone installed but not in contact with sample, press "Tare". The load cell zero is recorded in the audit trail.
  5. Positioning. Place the loaded female cone on the instrument platform so that the male cone is approximately centred 5–10 mm above the product surface. Use the centring jig to ensure coaxial alignment.
  6. Test initiation. Press "Start". The instrument descends at 2.0 mm/s until the 0.05 N trigger is detected, then switches to 3.0 mm/s test speed. Data acquisition begins at trigger detection.
  7. Test execution. The male cone descends 23.0 mm into the female cone, then withdraws at 10 mm/s. The full cycle takes approximately 10 s.
  8. Parameter extraction. The software automatically computes peak force (N), spreadability energy (N·mm), gradient over the first 5 mm (N/mm) and, if a withdrawal phase was recorded, work of adhesion (N·mm).
  9. Replicates. Clean the cones between replicates using the standard solvent protocol (isopropanol or water-alcohol as appropriate to the API), dry thoroughly, and repeat steps 1–8 a minimum of five times.
  10. Reporting. The software computes mean ± SD and %RSD across replicates and generates a signed PDF report containing the method ID, sample information, all raw curves, the parameter table, and the operator's electronic signature.
  11. Review and approval. The supervisor reviews the report, applies an independent electronic signature, and links the record to the batch documentation in the QMS. All changes and approvals are captured in the 21 CFR Part 11 audit trail.
KHT TA-30 Pharmaceutical Texture Analyzer

Ready to see the KHT TA-30 in your lab?

Transparent pricing $8,000–$13,000. IQ/OQ/PQ validation package included. 48-hour technical response SLA.

info@khtinstrument.com · Direct from manufacturer · No distributor markup